Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling
Identifieur interne : 006247 ( Main/Repository ); précédent : 006246; suivant : 006248Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling
Auteurs : RBID : Pascal:08-0527236Descripteurs français
English descriptors
Abstract
Background-Matrix metalloproteinase (MMP) activation plays a key role in vascular remodeling. RP782 is a novel indium 111In-labeled tracer with specificity for activated MMPs. We hypothesized that RP782 can detect injury-induced vascular remodeling in vivo. Methods and Results-Left common carotid artery injury was induced with a guidewire in apolipoprotein E-/- mice. Sham surgery was performed on the contralateral artery, which served as control for imaging experiments. Carotid wire injury led to significant hyperplasia and expansive remodeling over a period of 4 weeks. MMP activity, detected by in situ zymography, increased in response to injury and was maximal by 3 to 4 weeks after injury. RP782 (11.1 MBq) was injected intravenously into apolipoprotein E-/- mice at 1, 2, 3, and 4 weeks after left carotid injury. MicroSPECT imaging was performed at 2 hours and was followed by CT angiography to localize the carotid arteries. In vivo images revealed focal uptake of RP782 in the injured carotid artery at 2, 3, and 4 weeks. Increased tracer uptake in the injured artery was confirmed by quantitative autoradiography. Pretreatment with 50-fold excess nonlabeled tracer significantly reduced RP782 uptake in injured carotids, thus demonstrating uptake specificity. Weekly changes in the vessel-wall area closely paralleled and correlated with RP782 uptake (Spearman r=0.95, P=0.001). Conclusions-Injury-induced MMP activation in the vessel wall can be detected by RP782 microSPECT/CT imaging in vivo. RP782 uptake tracks the hyperplastic process in vascular remodeling and provides an opportunity to track the remodeling process in vivo.
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: 005F96
Links to Exploration step
Pascal:08-0527236Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling</title>
<author><name>JIASHENG ZHANG</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author><name>LEI NIE</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Razavian, Mahmoud" uniqKey="Razavian M">Mahmoud Razavian</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ahmed, Masood" uniqKey="Ahmed M">Masood Ahmed</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dobrucki, Lawrence W" uniqKey="Dobrucki L">Lawrence W. Dobrucki</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Asadi, Abolfazl" uniqKey="Asadi A">Abolfazl Asadi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Edwards, D Scott" uniqKey="Edwards D">D. Scott Edwards</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Lantheus Medical Imaging</s1>
<s2>North Billerica, Mass</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Lantheus Medical Imaging</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Azure, Michael" uniqKey="Azure M">Michael Azure</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Lantheus Medical Imaging</s1>
<s2>North Billerica, Mass</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Lantheus Medical Imaging</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sinusas, Albert J" uniqKey="Sinusas A">Albert J. Sinusas</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sadeghi, Mehran M" uniqKey="Sadeghi M">Mehran M. Sadeghi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New Haven, Conn</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="inist">08-0527236</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0527236 INIST</idno>
<idno type="RBID">Pascal:08-0527236</idno>
<idno type="wicri:Area/Main/Corpus">005F96</idno>
<idno type="wicri:Area/Main/Repository">006247</idno>
</publicationStmt>
<seriesStmt><idno type="ISSN">0009-7322</idno>
<title level="j" type="abbreviated">Circulation : (N. Y. N.Y.)</title>
<title level="j" type="main">Circulation : (New York, N.Y.)</title>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cardiovascular disease</term>
<term>Molecular imaging</term>
<term>Vascular remodeling</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Pathologie de l'appareil circulatoire</term>
<term>Remodelage vasculaire</term>
<term>Imagerie moléculaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background-Matrix metalloproteinase (MMP) activation plays a key role in vascular remodeling. RP782 is a novel indium <sup>111</sup>
In-labeled tracer with specificity for activated MMPs. We hypothesized that RP782 can detect injury-induced vascular remodeling in vivo. Methods and Results-Left common carotid artery injury was induced with a guidewire in apolipoprotein E<sup>-/-</sup>
mice. Sham surgery was performed on the contralateral artery, which served as control for imaging experiments. Carotid wire injury led to significant hyperplasia and expansive remodeling over a period of 4 weeks. MMP activity, detected by in situ zymography, increased in response to injury and was maximal by 3 to 4 weeks after injury. RP782 (11.1 MBq) was injected intravenously into apolipoprotein E<sup>-/-</sup>
mice at 1, 2, 3, and 4 weeks after left carotid injury. MicroSPECT imaging was performed at 2 hours and was followed by CT angiography to localize the carotid arteries. In vivo images revealed focal uptake of RP782 in the injured carotid artery at 2, 3, and 4 weeks. Increased tracer uptake in the injured artery was confirmed by quantitative autoradiography. Pretreatment with 50-fold excess nonlabeled tracer significantly reduced RP782 uptake in injured carotids, thus demonstrating uptake specificity. Weekly changes in the vessel-wall area closely paralleled and correlated with RP782 uptake (Spearman r=0.95, P=0.001). Conclusions-Injury-induced MMP activation in the vessel wall can be detected by RP782 microSPECT/CT imaging in vivo. RP782 uptake tracks the hyperplastic process in vascular remodeling and provides an opportunity to track the remodeling process in vivo.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0009-7322</s0>
</fA01>
<fA02 i1="01"><s0>CIRCAZ</s0>
</fA02>
<fA03 i2="1"><s0>Circulation : (N. Y. N.Y.)</s0>
</fA03>
<fA05><s2>118</s2>
</fA05>
<fA06><s2>19</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>JIASHENG ZHANG</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>LEI NIE</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>RAZAVIAN (Mahmoud)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>AHMED (Masood)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>DOBRUCKI (Lawrence W.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>ASADI (Abolfazl)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>EDWARDS (D. Scott)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>AZURE (Michael)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>SINUSAS (Albert J.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>SADEGHI (Mehran M.)</s1>
</fA11>
<fA14 i1="01"><s1>Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine Yale University School of Medicine</s1>
<s2>New Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>VA Connecticut Healthcare System</s1>
<s2>West Haven, Conn</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Lantheus Medical Imaging</s1>
<s2>North Billerica, Mass</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA20><s1>1953-1960</s1>
</fA20>
<fA21><s1>2008</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>5907</s2>
<s5>354000184333010070</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>39 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>08-0527236</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Circulation : (New York, N.Y.)</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Background-Matrix metalloproteinase (MMP) activation plays a key role in vascular remodeling. RP782 is a novel indium <sup>111</sup>
In-labeled tracer with specificity for activated MMPs. We hypothesized that RP782 can detect injury-induced vascular remodeling in vivo. Methods and Results-Left common carotid artery injury was induced with a guidewire in apolipoprotein E<sup>-/-</sup>
mice. Sham surgery was performed on the contralateral artery, which served as control for imaging experiments. Carotid wire injury led to significant hyperplasia and expansive remodeling over a period of 4 weeks. MMP activity, detected by in situ zymography, increased in response to injury and was maximal by 3 to 4 weeks after injury. RP782 (11.1 MBq) was injected intravenously into apolipoprotein E<sup>-/-</sup>
mice at 1, 2, 3, and 4 weeks after left carotid injury. MicroSPECT imaging was performed at 2 hours and was followed by CT angiography to localize the carotid arteries. In vivo images revealed focal uptake of RP782 in the injured carotid artery at 2, 3, and 4 weeks. Increased tracer uptake in the injured artery was confirmed by quantitative autoradiography. Pretreatment with 50-fold excess nonlabeled tracer significantly reduced RP782 uptake in injured carotids, thus demonstrating uptake specificity. Weekly changes in the vessel-wall area closely paralleled and correlated with RP782 uptake (Spearman r=0.95, P=0.001). Conclusions-Injury-induced MMP activation in the vessel wall can be detected by RP782 microSPECT/CT imaging in vivo. RP782 uptake tracks the hyperplastic process in vascular remodeling and provides an opportunity to track the remodeling process in vivo.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B12B03</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B02G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Pathologie de l'appareil circulatoire</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Remodelage vasculaire</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Vascular remodeling</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Remodelado vascular</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Imagerie moléculaire</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Molecular imaging</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fN21><s1>343</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=IndiumV3/Data/Main/Repository
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006247 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Repository/biblio.hfd -nk 006247 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= *** parameter Area/wikiCode missing *** |area= IndiumV3 |flux= Main |étape= Repository |type= RBID |clé= Pascal:08-0527236 |texte= Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling }}
This area was generated with Dilib version V0.5.77. |